In a genetically engineered mouse model, Rhim et al. demonstrated that pancreatic epithelial cells harboring oncogenic Kras mutation undergo EMT and intravasate from low-grade PanIN into the blood stream followed by dissemination to the liver already prior to primary tumor formation [13]. This evidence concerns the gene KRAS and neoplasm.